Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Donghoon Yoon

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentInternal Med, College of Medicine
DivisionInternal Med Hem-Onc
Address409 Cancer Institute
4104 Outpatient Circle
Mail Slot # 776
Little Rock AR 72205
Phone501-526-6990
ORCID ORCID Icon0000-0001-7295-3335 Additional info
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    CBHI CRAC23992     (YOON, DONGHOON)Jun 21, 2023 - Jun 20, 2028
    Calcium & Bone Health Institute
    Study of Sigma Anti-Bonding Calcium (SAC) Role(s) in Multiple Myeloma and Cutaneous Wound Healing
    Role: Principal Investigator
    P20GM125503     (OBRIEN, CHARLES A)Apr 1, 2023 - Jan 31, 2028
    NIH/Nat. Inst. of General Medical Sciences
    Center for Musculoskeletal Disease Research (CMDR)
    Role Description: Project Leader
    Role: Select
    CBHI CRA C23992     (YOON, DONGHOON)May 21, 2020 - Oct 31, 2024
    Calcium & Bone Health Institute
    Study of Sigma Anti-Bonding Calcium (SAC) Role(s) in Multiple Myeloma and Erythropoietin-Induced Osteoporosis
    Role: Principal Investigator
    R21OD026618     (YOON, DONGHOON)Aug 15, 2019 - Jul 31, 2022
    NIH/Office of the Director - Pass Through: University of Utah
    In Situ Imaging of Collagen Degradation Activity in Multiple Myeloma and Fibrosis Murine Models - Resubmission
    Role: Principal Investigator
    HHSF223201510172C     (JOHANN JR, DONALD J)Sep 30, 2015 - Mar 31, 2019
    U.S. Food and Drug Administration - Pass Through: Arkansas Research Alliance
    Scientific and methodological advancement in liquid biopsies to further the development of lung cancer-based precision medicine
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Mehdi SH, Xu YZ, Shultz LD, Kim E, Lee YG, Kendrick S, Yoon D. Development of New Diffuse Large B Cell Lymphoma Mouse Models. Cancers (Basel). 2024 Aug 29; 16(17). PMID: 39272864.
      View in: PubMed
    2. McCrury M, Swafford K, Shuttleworth SL, Mehdi SH, Acharya B, Saha D, Naceanceno K, Byrum SD, Storey AJ, Xu YZ, Doshier C, Patel V, Post GR, De Loose A, Rodriguez A, Shultz LD, Zhan F, Yoon D, Frett B, Kendrick S. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma. Mol Cancer Ther. 2024 Mar 04; 23(3):316-329. PMID: 37816504.
      View in: PubMed
    3. Mehdi SH, Gentry AC, Lee JY, Chung CP, Yoon D. The Synthetic Collagen-Binding Peptide NIPEP-OSS Delays Mouse Myeloma Progression. Cancers (Basel). 2023 Apr 26; 15(9). PMID: 37173940.
      View in: PubMed
    4. Tan JY, Li Y, Chamani F, Tharzeen A, Prakash P, Natarajan B, Sheth RA, Park WM, Kim A, Yoon D, Kim J. Experimental Validation of Diffraction Lithography for Fabrication of Solid Microneedles. Materials (Basel). 2022 Dec 14; 15(24). PMID: 36556744.
      View in: PubMed
    5. Mehdi SH, Morris CA, Lee JA, Yoon D. An Improved Animal Model of Multiple Myeloma Bone Disease. Cancers (Basel). 2021 Aug 25; 13(17). PMID: 34503090.
      View in: PubMed
    6. Mehdi SH, Nafees S, Mehdi SJ, Morris CA, Mashouri L, Yoon D. Animal Models of Multiple Myeloma Bone Disease. Front Genet. 2021; 12:640954. PMID: 34163520.
      View in: PubMed
    7. Bennink LL, Li Y, Kim B, Shin IJ, San BH, Zangari M, Yoon D, Yu SM. Visualizing collagen proteolysis by peptide hybridization: From 3D cell culture to in vivo imaging. Biomaterials. 2018 11; 183:67-76. PMID: 30149231.
      View in: PubMed
    8. Zangari M, Yoo H, Shin I, Kim B, Edmondson R, Morgan GJ, Suva LJ, Yoon D. Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice. Endocrinology. 2018 04 01; 159(4):1561-1569. PMID: 29381784.
      View in: PubMed
    9. Hildebrandt GC, Berno T, Gurule A, Mohan M, Yoon D, Salama M, Zangari M. Effect of low-dose bortezomib on bone formation in smouldering multiple myeloma. Br J Haematol. 2019 01; 184(2):308-310. PMID: 29574687.
      View in: PubMed
    10. Zangari M, Yoo H, Shin IJ, Yoon D, Suva LJ. Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma in vivo. J Bone Oncol. 2018 Sep; 12:19-22. PMID: 29556454.
      View in: PubMed
    11. Johann DJ, Steliga M, Shin IJ, Yoon D, Arnaoutakis K, Hutchins L, Liu M, Liem J, Walker K, Pereira A, Yang M, Jeffus SK, Peterson E, Xu J. Liquid biopsy and its role in an advanced clinical trial for lung cancer. Exp Biol Med (Maywood). 2018 02; 243(3):262-271. PMID: 29405770.
      View in: PubMed
    12. Mohan M, Samant RS, Yoon D, Buros AF, Branca A, Montgomery CO, Nicholas R, Suva LJ, Morello R, Thanendrarajan S, Schinke C, Yaccoby S, van Rhee F, Davies FE, Morgan GJ, Zangari M. Extensive Remineralization of Large Pelvic Lytic Lesions Following Total Therapy Treatment in Patients With Multiple Myeloma. J Bone Miner Res. 2017 Jun; 32(6):1261-1266. PMID: 28240368.
      View in: PubMed
    13. Divoky V, Song J, Horvathova M, Kralova B, Votavova H, Prchal JT, Yoon D. Delayed hemoglobin switching and perinatal neocytolysis in mice with gain-of-function erythropoietin receptor. J Mol Med (Berl). 2016 05; 94(5):597-608. PMID: 26706855.
      View in: PubMed
    14. Song J, Yoon D, Christensen RD, Horvathova M, Thiagarajan P, Prchal JT. HIF-mediated increased ROS from reduced mitophagy and decreased catalase causes neocytolysis. J Mol Med (Berl). 2015 Aug; 93(8):857-66. PMID: 26017143.
      View in: PubMed
    15. Zangari M, Berno T, Yang Y, Zeng M, Xu H, Pappas L, Tricot G, Kamalakar A, Yoon D, Suva LJ. Parathyroid hormone receptor mediates the anti-myeloma effect of proteasome inhibitors. Bone. 2014 Apr; 61:39-43. PMID: 24389365.
      View in: PubMed
    16. Tomasic NL, Piterkova L, Huff C, Bilic E, Yoon D, Miasnikova GY, Sergueeva AI, Niu X, Nekhai S, Gordeuk V, Prchal JT. The phenotype of polycythemia due to Croatian homozygous VHL (571C>G:H191D) mutation is different from that of Chuvash polycythemia (VHL 598C>T:R200W). Haematologica. 2013 Apr; 98(4):560-7. PMID: 23403324.
      View in: PubMed
    17. McClain DA, Abuelgasim KA, Nouraie M, Salomon-Andonie J, Niu X, Miasnikova G, Polyakova LA, Sergueeva A, Okhotin DJ, Cherqaoui R, Okhotin D, Cox JE, Swierczek S, Song J, Simon MC, Huang J, Simcox JA, Yoon D, Prchal JT, Gordeuk VR. Decreased serum glucose and glycosylated hemoglobin levels in patients with Chuvash polycythemia: a role for HIF in glucose metabolism. J Mol Med (Berl). 2013 Jan; 91(1):59-67. PMID: 23015148.
      View in: PubMed
    18. Yoon D, Ponka P, Prchal JT. Hypoxia. 5. Hypoxia and hematopoiesis. Am J Physiol Cell Physiol. 2011 Jun; 300(6):C1215-22. PMID: 21368293.
      View in: PubMed
    19. Swierczek SI, Yoon D, Bellann?-Chantelot C, Kim SJ, Saint-Martin C, Delhommeau F, Najman A, Prchal JT. Extent of hematopoietic involvement by TET2 mutations in JAK2V6?7F polycythemia vera. Haematologica. 2011 May; 96(5):775-8. PMID: 21273266.
      View in: PubMed
    20. Lee HJ, Maeng K, Dang HT, Kang GJ, Ryou C, Jung JH, Kang HK, Prchal JT, Yoo ES, Yoon D. Anti-inflammatory effect of methyl dehydrojasmonate (J2) is mediated by the NF-?B pathway. J Mol Med (Berl). 2011 Jan; 89(1):83-90. PMID: 20953575.
      View in: PubMed
    21. Perrotta S, Cucciolla V, Ferraro M, Ronzoni L, Tramontano A, Rossi F, Scudieri AC, Borriello A, Roberti D, Nobili B, Cappellini MD, Oliva A, Amendola G, Migliaccio AR, Mancuso P, Martin-Padura I, Bertolini F, Yoon D, Prchal JT, Della Ragione F. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors. PLoS One. 2010 Aug 05; 5(8):e12015. PMID: 20700488.
      View in: PubMed
    22. Bruchova-Votavova H, Yoon D, Prchal JT. miR-451 enhances erythroid differentiation in K562 cells. Leuk Lymphoma. 2010 Apr; 51(4):686-93. PMID: 20218812.
      View in: PubMed
    23. Yoon D, Okhotin DV, Kim B, Okhotina Y, Okhotin DJ, Miasnikova GY, Sergueeva AI, Polyakova LA, Maslow A, Lee Y, Semenza GL, Prchal JT, Gordeuk VR. Increased size of solid organs in patients with Chuvash polycythemia and in mice with altered expression of HIF-1alpha and HIF-2alpha. J Mol Med (Berl). 2010 May; 88(5):523-30. PMID: 20140661.
      View in: PubMed
    24. Hegde S, Ni S, He S, Yoon D, Feng GS, Watowich SS, Paulson RF, Hankey PA. Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation. Oncogene. 2009 Sep 24; 28(38):3349-59. PMID: 19581930.
      View in: PubMed
    25. Kim Y, Song J, Mays CE, Titlow W, Yoon D, Ryou C. Changes in gene expression of kringle domain-containing proteins in murine brains and neuroblastoma cells infected by prions. Mol Cell Biochem. 2009 Aug; 328(1-2):177-82. PMID: 19322640.
      View in: PubMed
    26. Bruchova H, Yoon D, Agarwal AM, Swierczek S, Prchal JT. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation. Blood Cells Mol Dis. 2009 Jul-Aug; 43(1):81-7. PMID: 19264517.
      View in: PubMed
    27. Yoon D, Agarwal N, Prchal JT. Does erythropoietin promote tumor growth? Clin Cancer Res. 2008 Mar 15; 14(6):1920; author reply 1920-1. PMID: 18347197.
      View in: PubMed
    28. Yoon D, Kim B, Prchal JT. Cre recombinase expression controlled by the hematopoietic regulatory domain of Gata-1 is erythroid-specific. Blood Cells Mol Dis. 2008 May-Jun; 40(3):381-7. PMID: 18077194.
      View in: PubMed
    29. Bruchova H, Yoon D, Agarwal AM, Mendell J, Prchal JT. Regulated expression of microRNAs in normal and polycythemia vera erythropoiesis. Exp Hematol. 2007 Nov; 35(11):1657-67. PMID: 17976518.
      View in: PubMed
    30. De Domenico I, Vaughn MB, Yoon D, Kushner JP, Ward DM, Kaplan J. Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations. Blood. 2007 Nov 15; 110(10):3780-3. PMID: 17726163.
      View in: PubMed
    31. Gaikwad A, Verstovsek S, Yoon D, Chang KT, Manshouri T, Nussenzveig R, Cortes J, Vainchenker W, Prchal JT. Imatinib effect on growth and signal transduction in polycythemia vera. Exp Hematol. 2007 Jun; 35(6):931-8. PMID: 17533047.
      View in: PubMed
    32. Yoon D, Pastore YD, Divoky V, Liu E, Mlodnicka AE, Rainey K, Ponka P, Semenza GL, Schumacher A, Prchal JT. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem. 2006 Sep 01; 281(35):25703-11. PMID: 16787915.
      View in: PubMed
    33. Mnjoyan Z, Yoon D, Li J, Delhommeau F, Afshar-Kharghan V. The effect of the JAK2 V617F mutation on PRV-1 expression. Haematologica. 2006 Mar; 91(3):411-2. PMID: 16503546.
      View in: PubMed
    34. Yoon D, Watowich SS. Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway. Exp Hematol. 2003 Dec; 31(12):1310-6. PMID: 14662339.
      View in: PubMed
    Yoon's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (215) concept(s)
    _
    Co-Authors Expand Description
    See all (21) people
    _
    Similar People Expand Description
    See all (41) people
    _
    Same Department Expand Description
    Search Department